[go: up one dir, main page]

AU2002213259A1 - Egf motif protein, egfl6 materials and methods - Google Patents

Egf motif protein, egfl6 materials and methods

Info

Publication number
AU2002213259A1
AU2002213259A1 AU2002213259A AU1325902A AU2002213259A1 AU 2002213259 A1 AU2002213259 A1 AU 2002213259A1 AU 2002213259 A AU2002213259 A AU 2002213259A AU 1325902 A AU1325902 A AU 1325902A AU 2002213259 A1 AU2002213259 A1 AU 2002213259A1
Authority
AU
Australia
Prior art keywords
egfl6
materials
methods
motif protein
egf motif
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002213259A
Inventor
Vinod Asundi
Radoje T Drmanac
John E. Ford
Chenghua Liu
Tom Y. Tang
Vicky Yamasaki
George Yeung
Jie Zhang
Hua Zhou
Ping Zhou
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hyseq Inc
Original Assignee
Hyseq Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hyseq Inc filed Critical Hyseq Inc
Publication of AU2002213259A1 publication Critical patent/AU2002213259A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU2002213259A 2000-10-13 2001-10-15 Egf motif protein, egfl6 materials and methods Abandoned AU2002213259A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US68786000A 2000-10-13 2000-10-13
US09/687,860 2000-10-13
PCT/US2001/032257 WO2002030977A2 (en) 2000-10-13 2001-10-15 Egf motif protein, egfl6 materials and methods

Publications (1)

Publication Number Publication Date
AU2002213259A1 true AU2002213259A1 (en) 2002-04-22

Family

ID=24762170

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002213259A Abandoned AU2002213259A1 (en) 2000-10-13 2001-10-15 Egf motif protein, egfl6 materials and methods

Country Status (5)

Country Link
US (1) US20040059098A1 (en)
EP (1) EP1356045A2 (en)
AU (1) AU2002213259A1 (en)
CA (1) CA2425833A1 (en)
WO (1) WO2002030977A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20060114381A (en) * 2004-02-13 2006-11-06 레프로셀 인코퍼레이티드 Feeder cell preparation medium and feeder cell for embryonic stem cell
KR101051435B1 (en) * 2008-10-22 2011-07-22 한국생명공학연구원 Colorectal cancer diagnostic kit using colorectal cancer-related markers and colorectal cancer diagnostic method using the same
TWI373345B (en) 2009-02-19 2012-10-01 Academia Sinica Breast cancer-targeting peptides and use thereof
US9850300B2 (en) 2013-03-15 2017-12-26 The Regents Of The University Of Michigan Compositions and methods relating to inhibiting cancer cell growth and/or proliferation
EP3411070A4 (en) 2016-02-05 2019-11-27 The Board of Regents of The University of Texas System SPECIFIC MONOCLONAL ANTIBODIES OF EGFL6 AND METHODS OF USING SAME

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5194596A (en) * 1989-07-27 1993-03-16 California Biotechnology Inc. Production of vascular endothelial cell growth factor
CA2309897A1 (en) * 1997-11-22 1999-06-03 Hyseq, Inc. A novel egf motif protein obtained from a cdna library of fetal liver-spleen

Also Published As

Publication number Publication date
WO2002030977A3 (en) 2003-08-28
WO2002030977A2 (en) 2002-04-18
CA2425833A1 (en) 2002-04-18
US20040059098A1 (en) 2004-03-25
EP1356045A2 (en) 2003-10-29

Similar Documents

Publication Publication Date Title
AU2001273164A1 (en) Membrane associated protein zupari
AU2001232799A1 (en) Protein c derivatives
AU6906800A (en) Membrane associated proteins
AU2002314181A1 (en) Novel endothelially expressed dnas and proteins, and their use
AU8146601A (en) AKT nucleic acids, polypeptides, and uses thereof
AU2001284418A1 (en) Novel polypeptide
AU5245900A (en) Novel protein and dna thereof
AU2001282037A1 (en) Proton-translocating retinal protein
AU2001274566A1 (en) Novel protein and dna thereof
AU2002213259A1 (en) Egf motif protein, egfl6 materials and methods
AU2001242750A1 (en) Novel protein, process for producing the same and use thereof
AU2001264955A1 (en) Human cyslt2 nucleic acids, polypeptides, and uses thereof
AU2001244863A1 (en) Apoptin-associating protein
AU2002239747A1 (en) Cystoskeleton-associated proteins
AU2002365189A1 (en) P85-alpha nucleic acids, polypeptides and related methods
AU1540701A (en) Novel protein
AU2002243234A1 (en) Embryogenesis associated proteins
AU2225401A (en) Novel protein and dna thereof
AU2001274563A1 (en) Novel polypeptide and its dna
AU2001257404A1 (en) 2246, novel protein kinase molecules and uses therefor
AU2001245974A1 (en) 3714, 16742, 23546, and 13887 novel protein kinase molecules and uses therefor
AU7304600A (en) Novel protein
AU2002500A (en) Novel protein
AU2001294267A1 (en) Survivin-like polypeptides and dnas thereof
AU2001278777A1 (en) Irap-binding protein